Pain is one of the most burdensome symptoms in people with cancer, and opioid analgesics
are considered the mainstay of cancer pain management. For this review, the authors …

Background: The prevalence of cancer-related pain and residual pain in cancer survivors is
high. Opioids serve as the gold standard for treating moderate to severe cancer pain. The …

The management of pain is an essential aspect of comprehensive cancer care. Positive
outcomes can be achieved in most patients with widely available therapies. There is a broad …

Most patients with cancer develop pain at some stage of their illness, and most of these
patients will require opioids for pain. In the Western world, we are “spoiled for choice” and …

Cancer pain is generally treated with pharmacological measures, relying on using opioids
alone or in combination with adjuvant analgesics. Weak opioids are used for mild-to …

Management of cancer pain has made sidnificant progress in recent years, partly due to the
Agency for Health Care Policy and Research (AHCPR) guidelines, but mostly it seems to be …

Most cancer pain can be managed effectively using analgesics according to World Health
Organization (WHO) guidelines. This involves a stepwise approach to the use of analgesic …

Refractory cancer pain that does not respond to standard opioid and/or co-analgesic therapy
occurs in 10–20% of patients. Risk factors include young age, neuropathic pain type …

Pain management remains a problem in advanced cancer. Despite the ready availability of
effective analgesia and good evidence to support the prescription of medications, concerns …

BACKGROUND: In all recommended guidelines put forth for the treatment of cancer pain,
opioids continue to be an important part of a physician's armamentarium. Though opioids …